Heparin-Associated Thrombocytopenia Treatment with Low Molecular Weight Heparin

Summary

Eight patients with heparin associated thrombocytopenia (HAT) were treated by a low molecular weight heparin derivative (LMW). Biological and clinical improvement occurred in all patients. This efficiency confirms the antithrombotic activity of LMW and allows its use in patients with HAT.

Key words

Heparin-associated thrombocytopenia - Thrombus formation - Low molecular weight heparin

• References

• 1 Babcock RB, Dumper CW, Scharfman WB. Heparin-induced immune thrombocytopenia. N Engl J Med 1976; 295: 237-241
• 2 Bell WR. Thrombocytopenia occurring during heparin therapy. N Engl J Med 1976; 295: 276-277
• 3 Hrushesky WJ. Subcutaneous heparin-induced thrombocytopenia. Arch Intern Med 1978; 138: 1489-1491
• 4 Kapsch DN, Adelstein EH, Rhodes GR, Silver D. Heparin-induced thrombocytopenia, thrombosis and hemorrhage. Surgery 1979; 86: 148-155
• 5 King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984; 100: 535-540
• 6 Kitzis M, Huisse MG, Hannoun L, Couffinhal JC, Dusaintpere C, Andreassian B. Thrombopénies induites par l’héparine. Diagnostic biologique et complications. Arch Mai Coeur 1980; 73: 1395-1404
• 7 Nelson JC, Lerner RG, Goldstein R, Cagin NA. Heparin-induced thrombocytopenia. Arch Intern Med 1978; 138: 548-552
• 8 Powers PJ, Kelton JG, Carter CJ. Studies on the frequency of heparin associated thrombocytopenia. Thromb Res 1984; 33: 439-443
• 9 Ramirez-Lassepas M, Cipolle RJ. Heparin and thrombocytopenia. Ann Intern Med 1984; 100: 613
• 10 Baird RA, Convery FR. Arterial thromboembolism in patients receiving systemic heparin therapy. J Bone Joint Surg (Am) 1977; 59 A: 1061-1064
• 11 Kapsch DN, Silver D. Heparin-induced thrombocytopenia with thrombosis and hemorrhage. Arch Surg 1981; 116: 1423-1427
• 12 Rhodes GR, Dixon RH, Silver D. Heparin-induced thrombocytopenia: Eight cases with thrombotic-hemorrhagic complications. Ann Surg 1977; 186: 752-758
• 13 Roussi JH, Houbouyan LL, Goguel AF. Use of low molecular weight heparin-induced thrombocytopenia with thrombotic complications. Lancet 1984; 8387: 1183
• 14 Trono DP, Kaelin RM, Thonney JL, Vader JP. Thrombocytopenia and heparin associated thrombosis. Ann Intern Med 1984; 100: 464-465
• 15 Aiach M, Michaud A, Balian JL, Lefebvre M, Woler M, Fourtillan J. A new low molecular weight heparin derivative, in vitro and in vivo studies. Thromb Res 1983; 31: 611-621
• 16 Hisse MG, Guillin MC, Bezeaud A, Toulemonde F, Kitzis M, Andreassian B. Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions. Thromb Res 1982; 27: 485-490
• 17 Follea G, Mandrand B, Dechavanne M. Simultaneous enzymo-immunologic assays of platelet associated IgG, IgM and C₃. A useful tool in assessment of immune thrombocytopenias. Thromb Res 1982; 26: 249-258
• 18 Harenberg J, Zimmermann R, Schwarz F, Kubler W. Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid. Lancet 1983; 8331: 986-987
• 19 Horellou MH, Conard J, Lecrubier C, Samama M, Roque-d’Orbcas-tel O, Fenoyl Ode, Di Maria G, Bernadou A. Persistent heparin induced thrombocytopenia despite therapy with low molecular weight heparin. Thromb Haemostas 1984; 51: 134-135
• 20 Kelton JG, Sheridan D, Brain H, Powers PJ, Turpie AG, Carter CJ. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 1984; 103: 606-612
• 21 Aiach M, Dreyfus G, Michaud A, Relland J, Murawski M, Leclerc M, Carpentier A. Low Molecular Weight (LMW) Heparin Derivatives in Experimental Extra Corporeal Circulation (ECC). Haemostasis 1984; 14: 325-332